James Smelser, M. D

NPI: 1881685089
Total Payments
$36,445
2024 Payments
$1,979
Companies
41
Transactions
477
Medicare Patients
8,690
Medicare Billing
$1.5M

Payment Breakdown by Category

Consulting$19,540 (53.6%)
Food & Beverage$11,373 (31.2%)
Travel$2,878 (7.9%)
Other$2,500 (6.9%)
Education$154.03 (0.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $19,540 8 53.6%
Food and Beverage $11,373 424 31.2%
Travel and Lodging $2,878 11 7.9%
Honoraria $2,500 1 6.9%
Education $154.03 33 0.4%

Top Paying Companies

Company Total Records Latest Year
CHF Solutions, Inc $25,805 34 $0 (2020)
Nuwellis, Inc. $2,782 6 $0 (2023)
Otsuka America Pharmaceutical, Inc. $1,229 59 $0 (2024)
AstraZeneca Pharmaceuticals LP $770.82 39 $0 (2024)
Fresenius USA Marketing, Inc. $744.66 36 $0 (2024)
Amgen Inc. $699.54 27 $0 (2024)
Relypsa, Inc. $657.57 47 $0 (2020)
OPKO Pharmaceuticals, LLC $613.15 75 $0 (2024)
Vifor Pharma, Inc. $455.05 25 $0 (2024)
CALLIDITAS THERAPEUTICS US INC. $366.91 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,979 94 CALLIDITAS THERAPEUTICS US INC. ($316.08)
2023 $1,273 57 Nuwellis, Inc. ($222.00)
2022 $721.33 36 Fresenius USA Marketing, Inc. ($197.74)
2021 $3,269 63 Nuwellis, Inc. ($2,560)
2020 $2,991 29 CHF Solutions, Inc ($2,597)
2019 $7,600 62 CHF Solutions, Inc ($6,478)
2018 $13,840 67 CHF Solutions, Inc ($13,036)
2017 $4,773 69 CHF Solutions, Inc ($3,694)

All Payment Transactions

477 individual payment records from CMS Open Payments — Page 1 of 20

Date Company Product Nature Form Amount Type
12/18/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $17.98 General
Category: Nephrology
12/17/2024 Cycle Pharmaceuticals Inc Tiopronin (Drug) Food and Beverage In-kind items and services $13.24 General
Category: UROLOGY
12/11/2024 Ardelyx, Inc. IBSRELA (Drug) Food and Beverage In-kind items and services $26.68 General
Category: GASTROENTEROLOGY
12/09/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $31.17 General
Category: CRITICAL CARE
11/26/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $22.05 General
Category: Nephrology
11/19/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $19.62 General
Category: NEPHROLOGY
11/18/2024 AKEBIA THERAPEUTICS INC Vafseo (Drug) Food and Beverage In-kind items and services $122.62 General
Category: Nephrology
11/18/2024 Fresenius USA Marketing, Inc. Velphoro (Drug) Food and Beverage In-kind items and services $13.08 General
Category: Phosphate binder for ESRD
11/07/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $121.60 General
Category: Nephrology
11/05/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $35.87 General
Category: CRITICAL CARE
11/04/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $27.05 General
Category: NEPHROLOGY
10/31/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $16.96 General
Category: NEPHROLOGY
10/31/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $4.72 General
Category: NEPHROLOGY
10/31/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Food and Beverage In-kind items and services $0.78 General
Category: NEPHROLOGY
10/30/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $19.32 General
Category: Nephrology
10/29/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $23.29 General
Category: Inflammation
10/16/2024 GlaxoSmithKline, LLC. BENLYSTA (Biological) Food and Beverage In-kind items and services $21.95 General
Category: IMMUNOLOGY
10/10/2024 Otsuka America Pharmaceutical, Inc. JYNARQUE (Drug) Food and Beverage In-kind items and services $26.94 General
Category: NEPHROLOGY
10/02/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $4.72 General
Category: NEPHROLOGY
09/25/2024 OPKO Pharmaceuticals, LLC RAYALDEE (Drug) Education In-kind items and services $4.72 General
Category: NEPHROLOGY
09/18/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $18.64 General
Category: Nephrology
09/16/2024 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $23.97 General
Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA
09/05/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $18.82 General
Category: Cardiovascular and Metabolism
09/04/2024 Amgen Inc. KRYSTEXXA (Biological) Food and Beverage In-kind items and services $20.23 General
Category: Inflammation/Rare Disease
08/13/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $27.10 General
Category: Nephrology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 15 1,747 3,265 $555,624 $283,570
2022 16 1,990 3,779 $632,649 $325,531
2021 16 2,284 4,511 $787,176 $426,149
2020 16 2,669 5,507 $1.0M $493,955
Total Patients
8,690
Total Services
17,062
Medicare Billing
$1.5M
Procedure Codes
68

All Medicare Procedures & Services

68 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2023 144 264 $132,000 $68,497 51.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 265 982 $98,200 $57,354 58.4%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 132 330 $42,900 $29,345 68.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 338 404 $52,520 $24,492 46.6%
90935 Hemodialysis procedure with physician evaluation Facility 2023 76 331 $57,925 $17,655 30.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 337 360 $34,200 $16,634 48.6%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2023 68 77 $38,500 $16,182 42.0%
90966 Home dialysis services per month (20 years or older) Office 2023 33 63 $31,500 $13,652 43.3%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 97 99 $19,800 $12,720 64.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 73 73 $12,775 $8,315 65.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 64 68 $9,316 $6,556 70.4%
90945 Dialysis procedure including 1 evaluation Facility 2023 19 69 $11,730 $4,282 36.5%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 56 94 $7,050 $3,458 49.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 15 17 $3,060 $1,984 64.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 13 17 $2,210 $1,240 56.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 17 17 $1,938 $1,205 62.2%
90960 Dialysis services, 4 or more physician visits per month (20 years or older) Office 2022 189 364 $182,000 $98,544 54.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 298 1,052 $105,200 $56,205 53.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 141 402 $52,260 $31,317 59.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 328 417 $48,594 $25,357 52.2%
90966 Home dialysis services per month (20 years or older) Office 2022 43 95 $47,500 $21,412 45.1%
90935 Hemodialysis procedure with physician evaluation Facility 2022 107 321 $56,175 $17,804 31.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 433 476 $35,095 $17,298 49.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 105 111 $21,670 $15,851 73.1%
90961 Dialysis services, 2-3 physician visits per month (20 years or older) Office 2022 51 55 $27,500 $12,345 44.9%

About James Smelser, M. D

James Smelser, M. D is a Nephrology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1881685089.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, James Smelser, M. D has received a total of $36,445 in payments from pharmaceutical and medical device companies, with $1,979 received in 2024. These payments were reported across 477 transactions from 41 companies. The most common payment nature is "Consulting Fee" ($19,540).

As a Medicare-enrolled provider, Smelser has provided services to 8,690 Medicare beneficiaries, totaling 17,062 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Huntsville, AL
  • Active Since 11/04/2005
  • Last Updated 09/13/2023
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1881685089

Products in Payments

  • Aquadex (Device) $25,805
  • AQUADEX SMARTFLOW CONSOLE (Device) $2,560
  • Veltassa (Drug) $1,082
  • JYNARQUE (Drug) $739.42
  • Velphoro (Drug) $514.09
  • SAMSCA (Drug) $504.84
  • Parsabiv (Biological) $441.23
  • RAYALDEE (Drug) $394.20
  • TARPEYO (Drug) $366.91
  • LOKELMA (Drug) $321.46
  • FARXIGA (Drug) $253.70
  • Aquadex Smartflow Console (Device) $222.00
  • Kerendia (Drug) $206.18
  • Rayaldee (Drug) $206.18
  • INJECTAFER (Drug) $181.94
  • BENLYSTA (Biological) $162.31
  • Vafseo (Drug) $122.62
  • XPHOZAH 30 MG (Drug) $121.19
  • ACTHAR (Biological) $119.99
  • KORSUVA (Drug) $109.99

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Huntsville